FOSSIL GROUP INC (FOSL)

US34988V1061 - Common Stock

1.27  -0.02 (-1.55%)

After market: 1.3 +0.03 (+2.36%)

Fundamental Rating

1

Taking everything into account, FOSL scores 1 out of 10 in our fundamental rating. FOSL was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. FOSL has a bad profitability rating. Also its financial health evaluation is rather negative. FOSL does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

FOSL had negative earnings in the past year.
FOSL had a positive operating cash flow in the past year.
FOSL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: FOSL reported negative operating cash flow in multiple years.

1.2 Ratios

FOSL has a worse Return On Assets (-19.40%) than 84.00% of its industry peers.
FOSL has a worse Return On Equity (-80.37%) than 78.00% of its industry peers.
Industry RankSector Rank
ROA -19.4%
ROE -80.37%
ROIC N/A
ROA(3y)-5.93%
ROA(5y)-5.51%
ROE(3y)-22.4%
ROE(5y)-19.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 49.18%, FOSL is in line with its industry, outperforming 54.00% of the companies in the same industry.
In the last couple of years the Gross Margin of FOSL has declined.
The Profit Margin and Operating Margin are not available for FOSL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.52%
GM growth 5Y-1.65%

3

2. Health

2.1 Basic Checks

FOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FOSL has more shares outstanding
The number of shares outstanding for FOSL has been increased compared to 5 years ago.
Compared to 1 year ago, FOSL has a worse debt to assets ratio.

2.2 Solvency

FOSL has an Altman-Z score of 1.70. This is a bad value and indicates that FOSL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.70, FOSL is doing worse than 74.00% of the companies in the same industry.
FOSL has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as FOSL would need 2.88 years to pay back of all of its debts.
FOSL has a Debt to FCF ratio (2.88) which is in line with its industry peers.
A Debt/Equity ratio of 0.83 indicates that FOSL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.83, FOSL is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 2.88
Altman-Z 1.7
ROIC/WACCN/A
WACC11.49%

2.3 Liquidity

FOSL has a Current Ratio of 1.94. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
FOSL's Current ratio of 1.94 is in line compared to the rest of the industry. FOSL outperforms 42.00% of its industry peers.
A Quick Ratio of 1.22 indicates that FOSL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.22, FOSL is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.22

0

3. Growth

3.1 Past

FOSL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.17%.
FOSL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.10%.
FOSL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.09% yearly.
EPS 1Y (TTM)-94.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17.5%
Revenue 1Y (TTM)-19.1%
Revenue growth 3Y-4.34%
Revenue growth 5Y-11.09%
Sales Q2Q%-19.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

FOSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of FOSL indicates a rather cheap valuation: FOSL is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.22
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FOSL!.
Industry RankSector Rank
Dividend Yield N/A

FOSSIL GROUP INC

NASDAQ:FOSL (10/8/2024, 8:00:01 PM)

After market: 1.3 +0.03 (+2.36%)

1.27

-0.02 (-1.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap67.48M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.4%
ROE -80.37%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 49.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.94
Quick Ratio 1.22
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-94.17%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.1%
Revenue growth 3Y-4.34%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y